Chris P Verschoor1,2, Vikas Kohli1,2, Cynthia Balion1,2. 1. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. 2. Canadian Longitudinal Study on Aging, Hamilton, Ontario, Canada.
Abstract
BACKGROUND: Monitoring the frequency and phenotype of white blood cell subsets using flow cytometry (immunophenotyping) has proven to be an incredibly powerful tool in the assessment of health. Although improved technologies have aided in the practical implementation of immunophenotyping in clinical and epidemiological studies, the transportation of blood from the site of collection to a central laboratory for analysis within a reasonable timeframe may not be feasible. Hence, the purpose of the following study was to investigate the validity of cryopreserved whole blood as a simple to prepare and cost-effective biospecimen for multi-colour immunophenotyping in a large epidemiological study-namely, The Canadian Longitudinal Study on Aging (CLSA). METHODS: In fresh and cryopreserved blood and cryopreserved peripheral blood mononuclear cells (PBMCs) we measured cellular viability and the quantities (absolute counts and relative frequencies) of total leukocytes, neutrophils, monocytes, CD4/CD8 T-lymphocytes, B-lymphocytes, natural killer (NK) cells, NKT cells, plasmacytoid dendritic cells (pDCs), and basophils. RESULTS: Estimates obtained from immunophenotyping in cryopreserved blood were comparable to fresh blood (Avg. rho: absolute cell counts = 0.71, frequency relative to CD45 leukocytes = 0.84, frequency relative to PBMCs = 0.86), cryopreserved PBMCs (0.86), and complete blood counts by hematological analyzer (0.71) and exhibited good intra- and inter-assay precision (Avg. CV = 4% and 3%, respectively). CONCLUSIONS: Given this, cryopreserved blood should be considered a feasible biospecimen in clinical and epidemiological studies requiring leukocyte immunophenotyping.
BACKGROUND: Monitoring the frequency and phenotype of white blood cell subsets using flow cytometry (immunophenotyping) has proven to be an incredibly powerful tool in the assessment of health. Although improved technologies have aided in the practical implementation of immunophenotyping in clinical and epidemiological studies, the transportation of blood from the site of collection to a central laboratory for analysis within a reasonable timeframe may not be feasible. Hence, the purpose of the following study was to investigate the validity of cryopreserved whole blood as a simple to prepare and cost-effective biospecimen for multi-colour immunophenotyping in a large epidemiological study-namely, The Canadian Longitudinal Study on Aging (CLSA). METHODS: In fresh and cryopreserved blood and cryopreserved peripheral blood mononuclear cells (PBMCs) we measured cellular viability and the quantities (absolute counts and relative frequencies) of total leukocytes, neutrophils, monocytes, CD4/CD8 T-lymphocytes, B-lymphocytes, natural killer (NK) cells, NKT cells, plasmacytoid dendritic cells (pDCs), and basophils. RESULTS: Estimates obtained from immunophenotyping in cryopreserved blood were comparable to fresh blood (Avg. rho: absolute cell counts = 0.71, frequency relative to CD45 leukocytes = 0.84, frequency relative to PBMCs = 0.86), cryopreserved PBMCs (0.86), and complete blood counts by hematological analyzer (0.71) and exhibited good intra- and inter-assay precision (Avg. CV = 4% and 3%, respectively). CONCLUSIONS: Given this, cryopreserved blood should be considered a feasible biospecimen in clinical and epidemiological studies requiring leukocyte immunophenotyping.
Authors: Era L Pogosova-Agadjanyan; Anna Moseley; Megan Othus; Frederick R Appelbaum; Thomas R Chauncey; I-Ming L Chen; Harry P Erba; John E Godwin; Min Fang; Kenneth J Kopecky; Alan F List; Galina L Pogosov; Jerald P Radich; Cheryl L Willman; Brent L Wood; Soheil Meshinchi; Derek L Stirewalt Journal: Biopreserv Biobank Date: 2017-11-27 Impact factor: 2.256
Authors: Chris P Verschoor; Lisa M McEwen; Vikas Kohli; Christina Wolfson; Dawn Me Bowdish; Parminder Raina; Michael S Kobor; Cynthia Balion Journal: BMC Genet Date: 2017-06-21 Impact factor: 2.797
Authors: Allison E Kennedy; Laura Cook; Jessica A Breznik; Braeden Cowbrough; Jessica G Wallace; Angela Huynh; James W Smith; Kiho Son; Hannah Stacey; Jann Ang; Allison McGeer; Brenda L Coleman; Maggie Larché; Mark Larché; Nathan Hambly; Parameswaran Nair; Kjetil Ask; Matthew S Miller; Jonathan Bramson; Megan K Levings; Ishac Nazy; Sarah Svenningsen; Manali Mukherjee; Dawn M E Bowdish Journal: Viruses Date: 2021-11-08 Impact factor: 5.048
Authors: Patrick Haider; Timothy Hoberstorfer; Manuel Salzmann; Michael B Fischer; Walter S Speidl; Johann Wojta; Philipp J Hohensinner Journal: Int J Mol Sci Date: 2022-02-07 Impact factor: 5.923
Authors: A Oras; B Quirant-Sanchez; D Popadic; S Thunberg; O Winqvist; S Heck; M Cwikowski; D Riemann; B Seliger; E Martinez Caceres; R Uibo; T Giese Journal: Clin Exp Immunol Date: 2020-08-03 Impact factor: 4.330